BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24088953)

  • 1. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice.
    Liu M; Reddy NM; Higbee EM; Potteti HR; Noel S; Racusen L; Kensler TW; Sporn MB; Reddy SP; Rabb H
    Kidney Int; 2014 Jan; 85(1):134-41. PubMed ID: 24088953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.
    Xu Z; Cho H; Hartsock MJ; Mitchell KL; Gong J; Wu L; Wei Y; Wang S; Thimmulappa RK; Sporn MB; Biswal S; Welsbie DS; Duh EJ
    J Neurochem; 2015 Apr; 133(2):233-41. PubMed ID: 25683606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X
    Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
    Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW
    Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.
    Reddy NM; Suryanaraya V; Yates MS; Kleeberger SR; Hassoun PM; Yamamoto M; Liby KT; Sporn MB; Kensler TW; Reddy SP
    Am J Respir Crit Care Med; 2009 Nov; 180(9):867-74. PubMed ID: 19679692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
    Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
    Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J
    Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation.
    Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE
    Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
    Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB
    Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
    Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S
    Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice.
    Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW
    Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene.
    Han P; Qin Z; Tang J; Xu Z; Li R; Jiang X; Yang C; Xing Q; Qi X; Tang M; Zhang J; Shen B; Wang W; Qin C; Zhang W
    Oxid Med Cell Longev; 2017; 2017():7612182. PubMed ID: 29435098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.
    Liu M; Grigoryev DN; Crow MT; Haas M; Yamamoto M; Reddy SP; Rabb H
    Kidney Int; 2009 Aug; 76(3):277-85. PubMed ID: 19436334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARĪ³, and HO-1.
    Wu QQ; Wang Y; Senitko M; Meyer C; Wigley WC; Ferguson DA; Grossman E; Chen J; Zhou XJ; Hartono J; Winterberg P; Chen B; Agarwal A; Lu CY
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1180-92. PubMed ID: 21289052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
    Sussan TE; Rangasamy T; Blake DJ; Malhotra D; El-Haddad H; Bedja D; Yates MS; Kombairaju P; Yamamoto M; Liby KT; Sporn MB; Gabrielson KL; Champion HC; Tuder RM; Kensler TW; Biswal S
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):250-5. PubMed ID: 19104057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
    Pitha-Rowe I; Liby K; Royce D; Sporn M
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Nrf2 in D-Galactose-Induced Cardiac Aging in Mice: Involvement of Oxidative Stress.
    Yang X; Jia J; Ding L; Yu Z; Qu C
    Gerontology; 2021; 67(1):91-100. PubMed ID: 33271531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.
    Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S
    Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
    Yates MS; Tran QT; Dolan PM; Osburn WO; Shin S; McCulloch CC; Silkworth JB; Taguchi K; Yamamoto M; Williams CR; Liby KT; Sporn MB; Sutter TR; Kensler TW
    Carcinogenesis; 2009 Jun; 30(6):1024-31. PubMed ID: 19386581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.